Uwe Bieri

[Uwe Bieri @UweBieri]

Bladder Wash cytology #Urology #Cytology #NMIBC

Limited Value of Bladder Wash Cytology During Follow-Up of Patients With Non-muscle Invasive Bladder Cancer https://t.co/RXIBB3wKAk

[Uwe Bieri @UweBieri]

Is Regular Radiographic Upper Urinary Tract Imaging for Surveillance🕵‍of Non-Muscle Invasive Bladder Cancer 🦀 Justified?
▶ check out our newest paper
https://t.co/uzjnz43274

#bladdercancer #UTUC #radiology @MDPIOpenAccess

[Guru P. Sonpavde, MD @sonpavde]

Modified Immunoscore (mIS) incorporating CD3, CD8, CD45RO, FOXP3->digital pathology prognostic (for PFS) in EORTC high-risk Non–Muscle-Invasive #bladdercancer (but not in low/intermediate risk disease)-@Unispital_USZ @CPMS1B @UweBieri
.https://t.co/csCYCzZpO9 @practiceupdate

[Uwe Bieri @UweBieri]

A modified #immunoscore showed potentially benefit in predicting prognosis in bladder cancer patients when compared to the TNM classification system alone. The study can be found here: https://t.co/DfvqeELHog

Feel free to contact us in case of questions. @UweBieri @CPMS1B

[Uwe Bieri @UweBieri]

How can we best identify #bladdercancer patients who might benefit from more close follow-up after #Cystectomy or from new #Adjuvant therapies in the future?

[Uwe Bieri @UweBieri]

BCG shortage is a problem that is always lurking in the corner. With our study, we are trying to use the microbiome to identify the patients who will actually benefit from BCG therapy. #BladderCancer #microbiome
funded by @krebsliga
���� https://t.co/31SC2BhBct

[Uwe Bieri @UweBieri]

https://t.co/3YXqFgCjwp

join our Research-Team
#JobOpening #USZ

[Uwe Bieri @UweBieri]

@tylerblack32 @Greg38589422 the peer review process is unfortunately not sufficient to detect these kinds of fundamental errors

[Uwe Bieri @UweBieri]

How can #urinary #retention be prevented after #hernia #TEP #surgery #tamsulosin #urology
On the route to evidence level 1 #RCT #ebm
The protocol has just been published in @BMJ_Open https://t.co/l0y50IkS0t

[ASN Publications @asnpublications]

New podcast alert: Dr. Marian Wettstein summarizes findings from a simulation study evaluating the management of active surveillance-eligible prostate cancer during pretransplantation workup. https://t.co/uCPLUQu6Ns